Symptomatic form of HFE-related hemochromatosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:465508OMIM:235200E83.1
Who is this for?
Show terms as
1Active trials8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Symptomatic HFE-related hemochromatosis is a genetic condition where the body absorbs too much iron from food. Over time, this excess iron builds up in organs such as the liver, heart, pancreas, and joints, causing damage. The disease is caused by mutations in the HFE gene, most commonly the C282Y mutation. While many people carry these mutations, only a portion develop the full symptomatic form of the disease, which means they have actual organ damage or significant symptoms from iron overload. Common symptoms include chronic fatigue, joint pain (especially in the hands), darkening or bronzing of the skin, liver problems (including cirrhosis), diabetes, heart problems, and sexual dysfunction due to hormonal changes. Men tend to develop symptoms earlier than women, often between ages 40 and 60, because women lose iron through menstruation and pregnancy, which delays iron buildup. The good news is that symptomatic hemochromatosis is one of the most treatable genetic conditions. The main treatment is therapeutic phlebotomy, which is essentially regular blood removal similar to blood donation. This lowers iron levels in the body and can prevent further organ damage. When caught early and treated consistently, many people with this condition can live normal, healthy lives. However, if organ damage has already occurred — particularly liver cirrhosis — some effects may not be fully reversible. Regular monitoring and lifelong management are essential.

Also known as:

Key symptoms:

Chronic fatigue and weaknessJoint pain, especially in the knuckles and fingersDarkening or bronzing of the skinLiver enlargement or liver diseaseDiabetes or high blood sugarHeart problems such as irregular heartbeat or heart failureLoss of sex drive or erectile dysfunctionAbdominal painMemory problems or difficulty concentrating (brain fog)Unexplained weight lossHair lossMood changes or depressionShortness of breathThyroid problems

Clinical phenotype terms (44)— hover any for plain English
Abnormality of iron homeostasisHP:0011031Elevated transferrin saturationHP:0012463ArthropathyHP:0003040HyperglycemiaHP:0003074Decreased muscle massHP:0003199Generalized bronze hyperpigmentationHP:0007574Testicular atrophyHP:0000029
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Jul 2021Impact of Transferrin Saturation Guided Maintenance Treatment on Quality of Life in HFE Haemochromatosis

Rennes University Hospital — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Symptomatic form of HFE-related hemochromatosis.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
N/A1 trial
Impact of Transferrin Saturation Guided Maintenance Treatment on Quality of Life in HFE Haemochromatosis
N/A
Actively Recruiting
· Sites: Bobigny; Limoges +10 more · Age: 1899 yrs

No specialists are currently listed for Symptomatic form of HFE-related hemochromatosis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Symptomatic form of HFE-related hemochromatosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Symptomatic form of HFE-related hemochromatosisForum →

No community posts yet. Be the first to share your experience with Symptomatic form of HFE-related hemochromatosis.

Start the conversation →

Latest news about Symptomatic form of HFE-related hemochromatosis

No recent news articles for Symptomatic form of HFE-related hemochromatosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How much iron overload do I currently have, and has it caused any organ damage?,How often will I need phlebotomy treatments, and how long will the initial treatment phase last?,Should my family members (siblings, children, parents) be tested for hemochromatosis?,Do I need screening for liver cancer or other complications, and how often?,Are there specific foods, supplements, or medications I should avoid?,Will my joint pain improve with treatment, or do I need additional management for that?,What ferritin and transferrin saturation levels are we targeting for my maintenance phase?

Common questions about Symptomatic form of HFE-related hemochromatosis

What is Symptomatic form of HFE-related hemochromatosis?

Symptomatic HFE-related hemochromatosis is a genetic condition where the body absorbs too much iron from food. Over time, this excess iron builds up in organs such as the liver, heart, pancreas, and joints, causing damage. The disease is caused by mutations in the HFE gene, most commonly the C282Y mutation. While many people carry these mutations, only a portion develop the full symptomatic form of the disease, which means they have actual organ damage or significant symptoms from iron overload. Common symptoms include chronic fatigue, joint pain (especially in the hands), darkening or bronzi

How is Symptomatic form of HFE-related hemochromatosis inherited?

Symptomatic form of HFE-related hemochromatosis follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Symptomatic form of HFE-related hemochromatosis typically begin?

Typical onset of Symptomatic form of HFE-related hemochromatosis is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Symptomatic form of HFE-related hemochromatosis?

Yes — 1 recruiting clinical trial is currently listed for Symptomatic form of HFE-related hemochromatosis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.